IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

NCT00349934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

BIOLOGICAL: IMP321

Sponsor

Immutep S.A.S.

Collaborators

[object Object]